The association between higher PD-L1 expression and African heritage has also been reported in triple-negative breast cancer and prostate cancer (49–51), indicating that the upregulation of immune checkpoint molecules may be a common biological pathway that increases cancer incidences among individuals of African descent. The gene discussed is CD274; the disease is prostate carcinoma.